Low AMH · Low ovarian reserve · Poor responder

Low AMH and low ovarian reserve

A number about how many eggs, not about whether you can have a child

Few results frighten people as much as a low AMH. It is usually delivered as a sentence rather than a measurement, and often by someone who has not explained what it does and does not predict.

What we investigate

Where this goes wrong

AMH counts the eggs that can be collected. It does not grade them, and it is not a fertility test

Anti-Müllerian hormone is produced by the small follicles in the ovary, so it estimates how many eggs could be retrieved in a stimulated cycle. That makes it genuinely useful for planning IVF: it predicts the size of the harvest.

What it does not do is grade the eggs, and it is a poor predictor of conceiving naturally. Egg quality tracks age far more closely than it tracks AMH, which is why a woman of 32 with a low AMH and a woman of 42 with the same value are in entirely different positions. Treating the number as a verdict is the most common mistake made with this test.

Consultation about a low AMH result at VITA Fertility Clinic, London

What we hear

Three versions of the same conversation

"They told me I was going into early menopause"

A single AMH taken while on the pill, or run by a lab using a different assay, becomes a diagnosis. Nobody repeated it, nobody counted the follicles on a scan, and nobody asked whether the periods had actually changed.

"They doubled the dose and nothing changed"

After a cycle with few eggs, the next one is run at maximum stimulation. Above a certain point, more drug does not produce more eggs — it mainly produces more side effects and a higher bill.

"I was told to buy supplements"

A list of adjuvants arrives before any explanation of what is actually limiting the cycle, and before anyone has checked whether there is a treatable reason for the reserve being low at this age.

If any of this sounds familiar, the useful first step is a confirmed picture: the test repeated properly, the follicles counted, and the reason for the number established before anything is prescribed.

What ovarian reserve actually is

The pool of eggs remaining in the ovaries. It is fixed before birth and declines throughout life, in everyone — a decline is not a disease. It is measured in two complementary ways: AMH in the blood, and the antral follicle count on a transvaginal scan. The two together are far more reliable than either alone, which is why a low AMH without a scan is an incomplete picture.

What "poor responder" means, and why the label matters

It describes how the ovaries responded to stimulation, not how fertile you are. The term has formal definitions: the ESHRE Bologna criteria of 2011, and the POSEIDON classification of 2016, which groups patients by age, ovarian reserve and previous response. POSEIDON exists precisely because "poor responder" was being applied to women in completely different situations — a 34-year-old whose unexpected low response needs explaining is not in the same position as a 41-year-old whose response matches her reserve. The group you fall into changes what is worth trying next.

The pathway

From a number to a plan

Four steps, in this order, because each one changes what the next is for.

1

Confirm the measurement

AMH repeated where the first value is doubtful or was taken on hormonal contraception, alongside an antral follicle count on scan. Values from different laboratories are read in the light of the assay used, not compared as if they were the same scale.

2

Ask why, if the reserve is low for your age

Under 40, a genuinely low reserve deserves an explanation: genetic, autoimmune, surgical or treatment-related. Some of those answers change what happens next, and some matter to your family as well as to you.

3

Read it next to everything else

Age, cycle history, tubal and uterine assessment, the male partner. A low AMH in a couple with an untreated male factor is not the thing limiting the outcome, and treating it as if it were wastes the time that matters most here.

4

Decide with real numbers

What a stimulated cycle is likely to yield, how many cycles the plan involves, and at what point egg freezing or donor eggs belong in the conversation — said plainly, early, rather than after three disappointing attempts.

What we investigate

Six areas. Not every one is needed in every case — which apply is decided after the first consultation, and you are told why.

01

The reserve itself

The two measurements that belong together, read against your age rather than against a population average.

  • AMH, repeated where the first value is doubtful or was taken on hormonal contraception
  • Antral follicle count by transvaginal ultrasound
  • Ovarian volume and the appearance of both ovaries
  • FSH and oestradiol, read together and timed to the cycle
  • The laboratory and assay used for any previous AMH

Hormonal contraception lowers AMH while it is being taken; a value measured on the pill is not your baseline.

02

Why the reserve is low, under 40

When the number does not match the age, there is often a reason — and finding it occasionally changes more than the fertility plan.

  • Karyotype
  • FMR1 premutation testing (fragile X), the commonest identifiable genetic cause
  • Thyroid function and thyroid antibodies
  • Adrenal antibodies where autoimmune ovarian insufficiency is suspected
  • History of ovarian surgery, endometriosis, chemotherapy or radiotherapy

An FMR1 premutation has implications for relatives as well as for you, which is why it is discussed before it is tested, never after.

03

The rest of the hormonal picture

Conditions that affect cycles and outcomes and are entirely treatable, so they are excluded before anything is blamed on the reserve.

  • TSH and free T4, with thyroid antibodies
  • Prolactin
  • Vitamin D
  • Androgens, where the history suggests it
  • Glucose and insulin where the metabolic picture calls for it
04

The uterus and the tubes

A limited number of eggs raises the cost of every other obstacle: with few attempts available, nothing avoidable should be left in the way.

  • Transvaginal ultrasound of the uterine cavity and endometrium
  • 3D ultrasound or hysteroscopy where a septum, polyp, fibroid or adhesion is suspected
  • Tubal patency assessment where it is relevant to the plan
  • Assessment for endometriosis and adenomyosis
05

The male partner

Assessed at the same time, not afterwards. Half of the obstacle sits here in a substantial share of couples.

  • Semen analysis to current WHO criteria
  • Sperm DNA fragmentation where the history points to it
  • Hormonal and clinical assessment by the andrologist
  • Lifestyle and occupational factors

Prof Fabio Castiglione, consultant urological surgeon and andrologist, sees the male partner at VITA.

06

Time, said honestly

Not a test, but part of the assessment: with a low reserve, the cost of waiting is higher than usual, and that deserves to be quantified rather than implied.

  • What the current numbers suggest about the next twelve months
  • Whether egg or embryo freezing is worth doing now rather than later
  • How many stimulated cycles the plan realistically involves
  • When donor eggs belong in the conversation, raised early rather than as a last resort

What actually changes the outcome

The honest list is shorter than the one usually offered, and the difference is mostly in what is left off it.

Stimulation matched to your reserve and to your previous response, rather than escalated by default — above a certain dose, more drug does not produce more eggs
Treating what is treatable first: thyroid, prolactin, vitamin D, the male factor, a uterine abnormality
Protocol changes chosen for a reason, with the previous cycle's response as the evidence
Accumulating embryos over more than one cycle, where that serves the plan better than a single attempt
Egg or embryo freezing while the reserve is what it is today
Donor eggs, discussed as a real option rather than a failure
Supplements and adjuvants such as DHEA, growth hormone or CoQ10: the evidence is limited and inconsistent, they are not standard care, and we say so rather than selling them as a solution

Why VITA

A number explained before it is acted on

Because the damage done by a badly explained AMH — decisions taken in fear, or years lost to false reassurance — is harder to undo than the result itself.

Dr Simone Rofena reviewing ovarian reserve results at VITA Fertility Clinic
25+ years in reproductive medicine, practising in London since 2013
AMH and antral follicle count read together, never one without the other
Both partners assessed in parallel, with an andrologist in the team
Evidence stated as it is, including where it is weak or absent

Questions

Frequently asked questions

Does a low AMH mean I cannot get pregnant naturally?

No. AMH estimates how many eggs could be collected in a stimulated cycle; it is a poor predictor of natural conception. Women with low AMH conceive naturally, and the chance depends far more on age, on the tubes and uterus, and on the male partner than on the value itself.

Does a low AMH mean my eggs are of poor quality?

It says nothing about quality. AMH is a measure of quantity. Egg quality follows age much more closely, which is why the same low value means something quite different at 32 and at 42.

Can AMH go up again?

Values fluctuate, and a result taken while on hormonal contraception is lower than your baseline and rises after stopping it. But the underlying decline in the egg pool does not reverse, and no treatment has been shown to reverse it. Anyone promising otherwise is selling something.

Am I going into early menopause?

A low AMH on its own is not that diagnosis. Primary ovarian insufficiency is diagnosed from the combination of cycle changes, repeated raised FSH and the clinical picture — not from a single AMH. If the suspicion is real it should be investigated properly, because it carries implications for bone and cardiovascular health as well as for fertility.

Will a higher dose of stimulation give me more eggs?

Only up to a point. Beyond the dose your ovaries can respond to, increasing it does not reliably increase the number of eggs collected; it increases side effects and cost. The useful change is usually the protocol and its timing, chosen on the evidence of how you responded last time.

Do DHEA, growth hormone or CoQ10 help?

The evidence is limited and inconsistent, and none of them is standard care. We would rather tell you that than add them to a plan so that something is being done. Where you are already taking them, we will say what is known and what is not.

Should I freeze my eggs now?

It is a question worth asking early rather than late, because what you can freeze depends on the reserve you have today. Whether it makes sense depends on your age, the numbers and what you want; the point is to make it a decision rather than something considered once the option has narrowed.

Do you carry out the IVF yourselves?

The assessment, the plan and the monitoring are done at VITA. The stimulated cycle itself takes place at a centre licensed by the HFEA, the UK regulator, under the same consultant who saw you.

The number is the beginning of the conversation

A low AMH tells you something real and narrow: how many eggs a stimulated cycle is likely to yield. It does not tell you whether you will have a child, and it should never be handed over as though it did.

What changes the outcome is knowing why the number is what it is, removing whatever else stands in the way, and deciding with real figures while the options are still open.

Have the result explained properly

Bring the AMH you already have, with the laboratory report and any previous cycle. The first consultation starts from what exists, not from a blank page.

Often the next step

When good embryos still do not implant

If the cycles have produced embryos and the transfers have not worked, the limiting factor is no longer the reserve. The implantation failure pathway looks at the embryo, the endometrium, the immune picture and the male factor together.

The implantation failure pathway at VITA Fertility Clinic
Dr Simone Rofena - Fertility Specialist

©2026 Dr Simone Rofena - Fertility Specialist

18 Dover Street, Mayfair, London W1S 4LT, United Kingdom

info@vitafertility.co.uk - +44 7863 928061